Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma Interventions: Procedure: TOMOX-HAIC; Drug: Sintilimab; Drug: Bevacizumab Sponsors: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials